
Dirección General de Medicamentos, Insumos y Drogas (Digemid)
government0.0Global Dominance: 0.00%
Digemid is the regulatory body responsible for overseeing medicines and health products in Peru, which faced delays in taking action against the defective saline solution after the Clínica Sanna failed to report adverse reactions promptly.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Digemid was unable to take timely measures to immobilize the defective product due to a delay in notification.
Caso Medifarma: Padres exigen justicia tras muerte de su hija por suero defectuoso en clínica de San Borja | Últimas | LIMAEl Comercio·
Peru· 2025-03-31



